article thumbnail

Building a digital therapeutic for paediatric behavioural health – the pharmaphorum podcast

pharmaphorum

Benny discusses SparkRx, Limbix’s product, and how it works, addressing the current regulatory landscape, how digital therapeutics interact with talk therapy and traditional therapeutics, and why it’s important to build a bespoke product for teens.

article thumbnail

Sanofi forges $30m alliance with digital health firm DarioHealth

pharmaphorum

DarioHealth has beefed up its sales and marketing channels as well as its range of digital health products thanks to a $30 million strategic alliance with drugmaker Sanofi. Erez Raphael.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

pharmaphorum

The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear noted that the grant comes at a time when many communities are seeing increased demand for behavioural health and recovery services amid the ongoing coronavirus pandemic.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Gani started BehaVR in 2016 to create DTx for mental and behavioural health.

article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Reagents supplier The Native Antigen Company has hired a new business development manager, Richard White , and senior product manager, Pardeep Sharda. Digital therapeutics hires.

article thumbnail

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

Like its earlier digital therapies for alcohol misuse and depression , Modia’s earlier-than-expected rollout stems from legislation that has made it possible to secure reimbursement for certain digital products for psychiatric disorders during the COVID-19 pandemic.

article thumbnail

Amwell dials in deals worth $320m to buy two digital health players

pharmaphorum

US telehealth group Amwell has agreed to buy two digital health specialists – SilverCloud Health and Conversa Health – as it looks to expand its services amid a boom in virtual healthcare delivery.